Teprotumumab Treatment for Thyroid-Associated Ophthalmopathy
Sign Up to like & getrecommendations! Published in 2020 at "European Thyroid Journal"
DOI: 10.1159/000507992
Abstract: Background: Thyroid-associated ophthalmopathy (TAO), an autoimmune process affecting the tissues surrounding the eye, most commonly develops in individuals with Graves’ disease. It is disfiguring, can cause vision loss, and dramatically lessens the quality of life… read more here.
Keywords: thyroid associated; treatment tao; treatment; teprotumumab treatment ... See more keywords